|
RELATED PARTY TRANSACTIONS
|
9 Months Ended |
|---|---|
|
Sep. 30, 2012
|
|
| Related Party Transactions [Abstract] | |
| Related Party Transactions Disclosure [Text Block] |
9. RELATED PARTY TRANSACTIONS
Jamey Weichert, the Company’s Chief Scientific Officer and principal founder of Cellectar, and a director and shareholder of the Company, is a faculty member at the University of Wisconsin-Madison (“UW”). During the three and nine months ended September 30, 2012, the Company made contributions to UW totaling $62,500 and $206,500 for use towards unrestricted research activities and paid UW $0 and $144,044 for costs associated with clinical trial and other research agreements. The Company made contributions to the UW of $62,500 and $125,000 during the three and nine months ended September 30, 2011. |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|